WMIS anticipates conclusion of the trial in 2012. CMS broad coverage approval is expected after trial results and the NOPR registry data are collected and published.
The World Molecular Imaging Society is a progressive organization that builds the school of thought, scientific paradigms and clinical practices of Molecular Imaging to advance the growing field of Molecular Medicine. The Academy and its journal are involved in the various technologies of molecular imaging and multimodalities formed by merging together imaging of biological processes with imaging anatomical structures within which these processes take place. This includes such technologies as PET, optical imaging, MRI, SPECT, CT and ultrasound. WMIS is the sponsor for the National Oncologic PET Registry (NOPR). To learn more about WMIS or to become a member, please visit the website at http://www.wmis.org.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/11/prweb8996220.htm